Invention Application
- Patent Title: THIENO-PYRIDINE DERIVATIVES AS MEK INHIBITORS
- Patent Title (中): 作为MEK抑制剂的三苯基吡啶衍生物
-
Application No.: US13760788Application Date: 2013-02-06
-
Publication No.: US20130150573A1Publication Date: 2013-06-13
- Inventor: Clive Martin Hutchings , Sarah Catherine Archibald , Daniel Christopher Brookings , Jeremy Martin Davis , James Andrew Johnson , Barry John Langham , Judi Charlotte Neuss
- Applicant: UCB Pharma S.A.
- Applicant Address: BE Brussels
- Assignee: UCB Pharma S.A.
- Current Assignee: UCB Pharma S.A.
- Current Assignee Address: BE Brussels
- Priority: GB0601962.4 20060131
- Main IPC: C07D495/04
- IPC: C07D495/04

Abstract:
Novel processes for the preparation of thieno[2,3-b]pyridine derivatives which are substituted in the 2-position by a substituted anilino moiety and intermediates thereto are provided. The compounds prepared by the present processes may be useful, for example, as selective inhibitors of human MEK (MAPKK) enzymes, and are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions. The present processes may offer improved yields, chemical or stereochemical purity, ease of preparation and/or isolation of intermediates and final product, and more industrially useful reaction conditions and workability.
Public/Granted literature
- US08604051B2 Thieno-pyridine derivatives as MEK inhibitors Public/Granted day:2013-12-10
Information query